[ Price : $8.95]
Eli Lilly says new Phase 2 data on weight-loss candidate retatrutide met primary and secondary endpoints.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection revision entitled Imports and Electronic Import Entries.[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of a Gemini Laboratories NDA for Oxandrin (oxandrolone) tablets and four ANDAs...[ Price : $8.95]
FDA warns Cambridge, MD-based Safe Chain Solutions about violations of the Drug Supply Chain Security Act in its work as a wholesa...[ Price : $8.95]
FDA publishes a guidance on how to present more consumer-friendly efficacy and risk information in direct-to-consumer promotional ...[ Price : $8.95]
Two Oncology Center of Excellence executives describe the benefits of the new QCARD initiative intended to improve study proposals...[ Price : $8.95]
Senate majority leader Chuck Schumer says FDA must develop a plan to deal with drug shortages and Congress must pursue a legislati...[ Price : $8.95]
FDA publishes a draft guidance about the prohibition on wholesaling of compounded drugs under Section 503B of the Federal Food, Dr...